ZOFRAN AND DEXTROSE IN PLASTIC CONTAINER Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Zofran And Dextrose In Plastic Container, and when can generic versions of Zofran And Dextrose In Plastic Container launch?
Zofran And Dextrose In Plastic Container is a drug marketed by Glaxosmithkline and is included in one NDA.
The generic ingredient in ZOFRAN AND DEXTROSE IN PLASTIC CONTAINER is ondansetron hydrochloride. There are twenty-eight drug master file entries for this compound. Sixty-three suppliers are listed for this compound. Additional details are available on the ondansetron hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Zofran And Dextrose In Plastic Container
A generic version of ZOFRAN AND DEXTROSE IN PLASTIC CONTAINER was approved as ondansetron hydrochloride by FRESENIUS KABI USA on December 26th, 2006.
Summary for ZOFRAN AND DEXTROSE IN PLASTIC CONTAINER
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 81 |
| Clinical Trials: | 161 |
| Patent Applications: | 1,392 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | ZOFRAN AND DEXTROSE IN PLASTIC CONTAINER at DailyMed |
Recent Clinical Trials for ZOFRAN AND DEXTROSE IN PLASTIC CONTAINER
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Tanta University | Phase 3 |
| Tanta University | Phase 2/Phase 3 |
| Emory University | Phase 2 |
See all ZOFRAN AND DEXTROSE IN PLASTIC CONTAINER clinical trials
Anatomical Therapeutic Chemical (ATC) Classes for ZOFRAN AND DEXTROSE IN PLASTIC CONTAINER
US Patents and Regulatory Information for ZOFRAN AND DEXTROSE IN PLASTIC CONTAINER
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Glaxosmithkline | ZOFRAN AND DEXTROSE IN PLASTIC CONTAINER | ondansetron hydrochloride | INJECTABLE;INJECTION | 020403-001 | Jan 31, 1995 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for ZOFRAN AND DEXTROSE IN PLASTIC CONTAINER
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Glaxosmithkline | ZOFRAN AND DEXTROSE IN PLASTIC CONTAINER | ondansetron hydrochloride | INJECTABLE;INJECTION | 020403-001 | Jan 31, 1995 | ⤷ Try a Trial | ⤷ Try a Trial |
| Glaxosmithkline | ZOFRAN AND DEXTROSE IN PLASTIC CONTAINER | ondansetron hydrochloride | INJECTABLE;INJECTION | 020403-001 | Jan 31, 1995 | ⤷ Try a Trial | ⤷ Try a Trial |
| Glaxosmithkline | ZOFRAN AND DEXTROSE IN PLASTIC CONTAINER | ondansetron hydrochloride | INJECTABLE;INJECTION | 020403-001 | Jan 31, 1995 | ⤷ Try a Trial | ⤷ Try a Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for ZOFRAN AND DEXTROSE IN PLASTIC CONTAINER
See the table below for patents covering ZOFRAN AND DEXTROSE IN PLASTIC CONTAINER around the world.
| Country | Patent Number | Title | Estimated Expiration |
|---|---|---|---|
| Hungary | 193592 | PROCESS FOR PRODUCING TETRAHYDRO-CARBAZOLONE DERIVATIVES | ⤷ Try a Trial |
| Denmark | 169521 | ⤷ Try a Trial | |
| Cyprus | 2000 | Use of a tetrahydrocarbazolone derivative for the manufacture of medicaments | ⤷ Try a Trial |
| Czech Republic | 9104043 | ⤷ Try a Trial | |
| United Kingdom | 8727836 | ⤷ Try a Trial | |
| New Zealand | 222743 | PHARMACEUTICAL AND VETERINARY COMPOSITION COMPRISING AN IMIDAZOLYL CARBAZOLONE AND RANITIDINE | ⤷ Try a Trial |
| >Country | >Patent Number | >Title | >Estimated Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - HIPAA-ready chat for life sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
